Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice

American Journal of Pathology

Volumn 170, Issue 4, 2007, Pages 1152-1164

  Pierce, Elizabeth M ^a   Carpenter, Kristin ^a   Jakubzick, Claudia ^a   Kunkel, Steven L ^a   Flaherty, Kevin R ^a   Martinez, Fernando J ^a   Hogaboam, Cory M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; HYDROXYPROLINE; INTERLEUKIN 13; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CCL6; MONOCLONAL ANTIBODY CCR7; PROTEIN CCL21; UNCLASSIFIED DRUG; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 7; CCL6 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; CYTOKINE; SCLEROPROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FIBROSING ALVEOLITIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNE DEFICIENCY; IN VIVO STUDY; INTERSTITIAL PNEUMONIA; LIGAND BINDING; LUNG BIOPSY; LUNG FIBROSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; ADOPTIVE TRANSFER; ANIMAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAVENOUS DRUG ADMINISTRATION; LUNG; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; CHEMOKINES, CC; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; HYDROXYPROLINE; INJECTIONS, INTRAVENOUS; INTERLEUKIN-13; LUNG; MICE; MICE, INBRED ICR; MICE, SCID; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; RECEPTORS, CHEMOKINE; TRANSCRIPTION, GENETIC;

EID: 34247862243     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060649     Document Type: Article

References (44)

1. American Thoracic Society/European Respiratory Society (ATS/ERS) international multidisciplinary consensus classification of idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165:277-304
2. Antoniou KM, Pataka A, Bouros D, Siafakas NM: Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 2006 [Epub ahead of Print]
3. Strieter RM: Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005, 128:526S-532S
4. Zisman DA, Keane MP, Belperio JA, Strieter RM, Lynch III JP: Pulmonary fibrosis. Methods Mol Med 2005, 117:3-44
5. Swigris JJ, Kuschner WG, Kelsey JL, Gould MK: Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest 2005, 127:275-283
6. Keane MP, Arenberg DA, Lynch JP III, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Strieter RM: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997, 159:1437-1443
7. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001, 24:591-598
8. White ES, Atrasz RG, Hu B, Phan SH, Stambolic V, Mak TW, Hogaboam CM, Flaherty KR, Martinez FJ, Kontos CD, Toews GB: Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). Am J Respir Crit Care Med 2006, 173:112-121
9. Jakubzick C, Choi ES, Carpenter KJ, Kunkel SL, Evanoff H, Martinez FJ, Flaherty KR, Toews GB, Colby TV, Travis WD, Joshi BH, Puri RK, Hogaboam CM: Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol 2004, 164:1989-2001
10. Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch III JP: Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004, 64:405-430
11. Quan TE, Cowper SE, Bucala R: The rote of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006, 8:145-150
12. Lama VN, Phan SH: The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006, 3:373-376
13. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA: Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 2000, 97:1778-1783
14. Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, Becerril C, Yousem S, Herrera I, Ruiz V, Selman M, Kaminski N: Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005, 2:e251
15. Choi ES, Jakubzick C, Carpenter KJ, Kunkel SL, Evanoff H, Martinez FJ, Flaherty KR, Toews GB, Colby TV, Kazerooni EA, Gross BH, Travis WD, Hogaboam CM: Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am J Respir Crit Care Med 2004, 170:508-515
16. Gharaee-Kermani M, Ullenbruch M, Phan SH: Animal models of pulmonary fibrosis. Methods Mol Med 2005, 117:251-259
17. Chua F, Gauldie J, Laurent GJ: Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005, 33:9-13
18. Gauldie J: Pro: inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 165:1205-1206
19. Strieter RM: Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 165:1206-1207; discussion 1207-1208
20. Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, Travis WD, Mumford JA, Murray S, Flint A, Lynch JP III, Martinez FJ: Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003, 58:143-148
21. Agostini C, Gurrieri C: Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006, 3:357-363
22. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999, 103:779-788
23. Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM: Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol Res 2004, 30:339-350
24. Belperio JA, Dy M, Burdick MD, Xue YY, Li K, Elias JA, Keane MP: Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2002, 27:419-427
25. Choi ES, Pierce EM, Jakubzick C, Carpenter KJ, Kunkel SL, Evanoff H, Martinez FJ, Flaherty KR, Moore BB, Toews GB, Colby TV, Kazerooni EA, Gross BH, Travis WD, Hogaboam CM: Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J Clin Pathol 2006, 59:28-39
26. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM: The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 1999, 162:3859-3864
27. Jakubzick C, Choi ES, Joshi BH, Keane MP, Kunkel SL, Puri RK, Hogaboam CM: Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol 2003, 171:2684-2693
28. Jakubzick C, Choi ES, Kunkel SL, Joshi BH, Puri RK, Hogaboam CM: Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts. Am J Pathol 2003, 162:1475-1486
29. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH: Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 1994, 153:4733-4741
30. Ryu JH, Colby TV, Hartman TE: Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc 1998, 73:1085-1101
31. Jakubzick C, Wen H, Matsukawa A, Keller M, Kunkel SL, Hogaboam CM: Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am J Pathol 2004, 165:1211-1221
32. Banas B, Wornle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, Pfirstinger J, Mack M, Lipp M, Grone HJ, Schlondorff D: Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 2002, 168:4301-4307
33. Bonacchi A, Petrai I, Defranco RM, Lazzeri E, Annunziato F, Efsen E, Cosmi L, Romagnani P, Milani S, Failli P, Batignani G, Liotta F, Laffi G, Pinzani M, Gentilini P, Marra F: The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003, 125:1060-1076
34. Jenh CH, Cox MA, Kaminski H, Zhang M, Byrnes H, Fine J, Lundell D, Chou CC, Narula SK, Zavodny PJ: Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. J Immunol 1999, 162:3765-3769
35. Hammad H, Lambrecht BN, Pochard P, Gosset P, Marquillies P, Tonnel AB, Pestel J: Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol 2002, 169:1524-1534
36. Skovseth DK, Yamanaka T, Brandtzaeg P, Butcher EC, Haraldsen G: Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice. Am J Pathol 2002, 160:1629-1637
37. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556-7562
38. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004, 113:243-252
39. Kimura M, Tani K, Miyata J, Sato K, Hayashi A, Otsuka S, Urata T, Sone S: The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases. J Med Invest 2005, 52:93-100
40. Wattiez R, Hermans C, Cruyt C, Bernard A, Falmagne P: Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 2000, 21:2703-2712
41. Pardo A, Selman M: Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc 2006, 3:383-388
42. Kuhn C, Mason RJ: Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 1995, 147:1759-1769
43. Adachi K, Yamauchi K, Bernaudin JF, Fouret P, Ferrans VJ, Crystal RG: Evaluation of fibronectin gene expression by in situ hybridization: differential expression of the fibronectin gene among populations of human alveolar macrophages. Am J Pathol 1988, 133:193-203
44. Mauch C: Matrix metalloproteinase-19: what role does this enzyme play in wound healing? J Invest Dermatol 2003, 121:xix-xx